Patent · US Expired

Pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system for the release of 17-&bgr;-estradiol to the human organism

US6623763B2 · kind B2 · utility

2Cited by
2References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 19, 2001
Grant dateSep 23, 2003
Priority date
Expiry dateNov 14, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/565
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical preparation adhering to the skin, in particular a transdermal therapeutic system, for the release of the active substance 17-&bgr;-estradiol, contained therein in dissolved form being between its saturation concentration in equilibrium with a gas phase of less than 10% relative air humidity and its saturation concentration in equilibrium with a gas phase of more than 90% relative air humidity, in all matrix levels and, if present, also in an adhesive layer, characterized in that the estradiol quantity contained in in the preparation amounts to at least three times the saturation solubility measured at 95% relative air humidity, and that the air enclosed in the package is adjusted to a relative air humidity between 5% and below 0.5%.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.